CompletedNot Applicable

The Role of oAncreatic Enzyme ReplAcement Therapy (PERT) on Mucosal Visibility Before Upper GI Endoscopy

Romania42 participantsStarted 2024-08-01

Plain-language summary

The investigators aim to establish wether the administration of pancreatic enzyme replacement therapy (PERT) improves visibility of the mucosa during upper gastrointestinal endoscopy.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * patient with upper gastrointestinal endoscopy indication, with topical pharyngeal anesthesia * age above 18 years old * informed consent Exclusion Criteria: * allergy to KREON and/or sodium bicarbonate * upper gastrointestinal bleeding clinically manifest (hematemesis, melena, hematochesia) * ingested foreign body * personal history of esophagectomy, partial or total gastectomy * absence of informed consent

What they're measuring

Crema Stomach Cleaning Score (CSCS)

Timeframe: 2 hours

Trial details

NCT IDNCT06218537

SponsorCarol Davila University of Medicine and Pharmacy

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-08-31

View on ClinicalTrials.gov More Upper Gastrointestinal Endoscopy trials